CA Patent

CA2495454A1 — Pharmaceutical compositions for inhalation containing a new anticholinergic in conjunction with corticosteroids and betamimetics

Assigned to Boehringer Ingelheim Pharma GmbH and Co KG · Expires 2004-03-18 · 22y expired

What this patent protects

The invention relates to novel medicament compositions based on a novel anticholinesterase drug, corticosteroids and betamimetic drugs, to methods f or the production thereof, and to their use in the treatment of respiratory illnesses.

USPTO Abstract

The invention relates to novel medicament compositions based on a novel anticholinesterase drug, corticosteroids and betamimetic drugs, to methods f or the production thereof, and to their use in the treatment of respiratory illnesses.

Drugs covered by this patent

Patent Metadata

Patent number
CA2495454A1
Jurisdiction
CA
Classification
Expires
2004-03-18
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.